Boston Scientific shares fall as key segment's performance spooks investors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Boston Scientific (BSX) PT Lowered to $105 at Piper Sandler, 'Buy The Dip'
February 4, 2026 9:46 AM EST(Updated - February 4, 2026 9:52 AM EST)
Piper Sandler analyst Matt O\'Brien lowered the price target on Boston Scientific (NYSE: BSX) to $105.00 (from $120.00) while maintaining a Overweight rating.
"Q4 Beat But Key Drivers Deceleration to Weight on Stock; Buy The Dip"... More